Biopsy Misidentification Identified by DNA Profiling in a Large Multicenter Trial

PURPOSE: The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) prostate cancer risk reduction study randomly assigned 8,231 men to dutasteride or placebo for 4 years. Protocol-mandated biopsies were obtained after 2 and 4 years. After the discovery of three cases of biopsy sample misidenti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Marberger, Michael, McConnell, John D., Fowler, Ivy, Andriole, Gerald L., Bostwick, David G., Somerville, Matthew C., Rittmaster, Roger S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2011
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107764/
https://ncbi.nlm.nih.gov/pubmed/21444877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.1646
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak